NGL Fine-Chem Limited Recommends Final Dividend for the Year Ended on March 31, 2021, Payable on or After August 27, 2021
June 01, 2021 at 09:27 am
Share
NGL Fine-Chem Limited at its board meeting held on June 1, 2021, recommended final dividend of INR 1.75 per fully paid up equity share of INR 5 each for the financial year ended on March 31, 2021, payable on or after August 27, 2021. The record date for the purpose of payment of final dividend is August 13, 2021.
NGL Fine-Chem Limited is an India-based company, which is a manufacturer of pharmaceuticals and intermediates for use in veterinary and human health. The Company caters to various global companies to custom manufacture pharmaceuticals. Its products include APIs Animal Health, APIs Human Health, Intermediates and Specialty Chemicals and Finished Dosage Form. The APIs Animal Health products include Homidium Chloride, Nitroxynil, Clorsulon, Parvaquone, Buparvaquone, Isometamidium Chloride Hydrochloride, Toldimfos Sodium, Butaphosphan, Imidocarb Dipropionate, Triclabendazole, Rafoxanide, Diminazene Aceturate, S-Methoprene, Carprofen and others. The APIs Human Health products include Nitazoxanide and Atovaquone. The Intermediates and Specialty Chemicals product includes 1,4,7-Trimethyl-1,4,7-Triazacylononane and N-Ethyl Glucamine. The Finished Dosage Form products include Diminazene Aceturate Granules and Homidium Chloride Tablets. It has manufacturing plants located around Mumbai.
NGL FINE-CHEM LIMITED 
